Author:
Agero Anna Liza C.,Dusza Stephen W.,Benvenuto-Andrade Cristiane,Busam Klaus J.,Myskowski Patricia,Halpern Allan C.
Reference57 articles.
1. Targeted therapies for cancer 2004;Ross;Am J Clin Pathol,2004
2. The EGF receptor—an essential regulator of multiple epidermal functions;Jost;Eur J Dermatol,2000
3. The erbB family: targets for therapeutic development against cancer and therapeutic strategies using monoclonal antibodies and tyrosine kinase inhibitors;Rowinsky;Annu Rev Med,2004
4. Safety, pharmacokinetics, and activity of ABX-EGF, a fully human anti-epidermal growth factor receptor monoclonal antibody in patients with metastatic renal cell cancer;Rowinsky;J Clin Oncol,2004
5. ZD1839, a selective oral epidermal growth factor receptor-tyrosine kinase inhibitor, is well tolerated and active in patients with solid, malignant tumors: results of a phase I trial;Ranson;J Clin Oncol,2002
Cited by
306 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献